IDEXX Laboratories (IDXX) Earnings Analysis

IDEXX Laboratories (IDXX) has no confirmed upcoming earnings date. Last quarter (2026-02-02) it beat with EPS 3.08 USD vs 2.93 USD est (+5.1%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 39.87.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IDXX next report earnings?

No confirmed upcoming earnings date is currently scheduled for IDXX. This page updates as the calendar is published.

IDXX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-023.08 USD2.93 USD+5.1%Beat
2025-11-033.4 USD3.14 USD+8.3%Beat
2025-08-043.63 USD3.28 USD+10.7%Beat
2025-05-012.96 USD2.85 USD+3.9%Beat
2025-02-032.62 USD2.39 USD+9.6%Beat
2024-10-312.8 USD2.68 USD+4.5%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

IDXX valuation and analyst view

Trailing P/E39.87
Trailing EPS13.674 USD
Price / book28.05
Dividend yield0.00%
Market cap43.29B
Analyst consensusBuy (13 buy / 8 hold / 1 sell)
Avg price target640 USD

Related research pages

Frequently asked questions

When is IDEXX Laboratories (IDXX)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for IDXX. This page updates as the calendar is published.

Did IDXX beat earnings last quarter?

In its 2026-02-02 report, IDXX posted EPS of 3.08 USD versus a 2.93 USD estimate — a beat of 5.1%.

What is IDXX's earnings track record?

Over the last 6 reported quarters with consensus data, IDXX beat estimates 6 times (100%).

What is IDXX's current P/E ratio and EPS?

IDXX trades at a trailing P/E of 39.87 on trailing EPS of 13.674003695565322 USD.

What do analysts rate IDXX?

Analyst consensus is "Buy" across 22 ratings (0 strong buy, 13 buy, 8 hold, 1 sell, 0 strong sell). Average 12-month price target: 640 USD.